{"id":559918,"date":"2021-08-26T18:00:02","date_gmt":"2021-08-26T18:00:02","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=559918"},"modified":"2021-08-26T18:00:02","modified_gmt":"2021-08-26T18:00:02","slug":"digital-pathology-market-worth-1054-million-by-2025-key-players-are-leica-biosystems-us-koninklijke-philips-nv-netherlands","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/digital-pathology-market-worth-1054-million-by-2025-key-players-are-leica-biosystems-us-koninklijke-philips-nv-netherlands_559918.html","title":{"rendered":"Digital Pathology Market worth $1,054 million by 2025 | Key Players are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands)"},"content":{"rendered":"<div style=\"float:right; width:250px; padding:8px 10px 10px 10px;\">\n<div><a href=\"https:\/\/www.abnewswire.com\/uploads\/1629974506.jpeg\" style=\"border:none !important;\" target=\"_blank\" rel=\"nofollow\" ><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29\" title=\"Digital Pathology Market worth $1,054 million by 2025 | Key Players are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands)\" src=\"https:\/\/www.abnewswire.com\/uploads\/1629974506.jpeg\" alt=\"Digital Pathology Market worth $1,054 million by 2025 | Key Players are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands)\" width=\"225\" height=\"225\" style=\"padding:0px 0px 10px 10px; border:0 solid !important;\" \/><\/a><\/div>\n<div class=\"quotes\">\n<div>The major players in the global digital pathology market are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan). Other prominent players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (Canada), Visiopharm A\/S (Denmark), Corista (US), Indica Labs (US), Objective Pathology Services (Canada)<\/div>\n<\/div>\n<\/div>\n<div style=\"font-style:italic; padding:8px 0px;\">Digital Pathology Market Research Report Provides Crucial Industry Insights. Industry to Witness a Steady Growth in Near Future.<\/div>\n<p style=\"text-align: justify;\">According to the new market research report&nbsp;<strong>&#8220;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/digital-pathology-market-844.html?utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\"  target=\"_blank\">Digital Pathology Market<\/a><strong>&nbsp;by Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Disease Diagnosis, Drug Discovery), End-User (Pharmaceutical Companies, Hospitals) &#8211; Global Forecast to 2025&#8243;,<\/strong>&nbsp;published by MarketsandMarkets&trade;, the Digital Pathology Market&nbsp;is projected to reach&nbsp;<span class=\"xn-money\">USD 1,054 million<\/span>&nbsp;by 2025 from&nbsp;<span class=\"xn-money\">USD 553 million<\/span>&nbsp;in 2020, at a CAGR of 13.8% during the forecast period.<\/p>\n<p style=\"text-align: justify;\"><em>Browse in-depth TOC on&nbsp;<\/em>&#8220;Digital Pathology Market&#8221;<\/p>\n<p style=\"text-align: justify;\"><strong>192 &ndash; Tables<br class=\"dnr\" \/>42 &ndash; Figures<br class=\"dnr\" \/>210 &ndash; Pages<\/strong><\/p>\n<p style=\"text-align: justify;\"><strong>Download PDF Brochure:<\/strong><\/p>\n<p style=\"text-align: justify;\"><a href=\"https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=844\"  target=\"_blank\">https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=844<\/a><\/p>\n<p style=\"text-align: justify;\">The growth of this market is majorly attributed to the increasing adoption of digital pathology to enhance lab efficiency, rising prevalence of cancer, growing application of digital pathology in drug development &amp; companion diagnostics, and increasing initiatives by industry players.<\/p>\n<p style=\"text-align: justify;\"><strong>By product, the scanners segment accounted for the largest market share in 2019.<\/strong><\/p>\n<p style=\"text-align: justify;\">On the basis of product, the digital pathology market is segmented into scanners, software, communication systems, and storage systems. The scanners segment accounted for the largest share of the market in 2019. The large share of this segment is mainly due to the increasing adoption of digital pathology solutions across the globe. However, the software segment is projected to witness the highest growth rate during the forecast period due to the availability of user-friendly, analytical, and advanced functions for pathology diagnosis.<\/p>\n<p style=\"text-align: justify;\"><strong>The drug discovery segment commanded the largest share of the digital pathology market, by application, in 2019.<\/strong><\/p>\n<p style=\"text-align: justify;\">On the basis of application, the market has been segmented into drug discovery, disease diagnosis, teleconsultation, and training &amp; education. The drug discovery segment accounted for the largest share of the market in 2019. Factors such as the growth in R&amp;D expenditure, fuelled by the need for numerous preclinical and clinical studies performed during the drug discovery and development process is one of the major factors driving the growth of this segment.<\/p>\n<p style=\"text-align: justify;\"><strong>Pharmaceutical &amp; biotechnology companies are the largest end-user segment of the digital pathology market.<\/strong><\/p>\n<p style=\"text-align: justify;\">On the basis of end-users, the market is segmented into pharmaceutical &amp; biotechnology companies, hospitals and reference laboratories, and academic &amp; research institutes. The pharmaceutical &amp; biotechnology companies segment accounted for the largest share of the global market, by end-user, in 2019. Factors contributing to the large share and high growth rate of this segment include the increasing use of digital pathology for drug discovery studies and drug toxicology testing. Biotechnology companies also use digital pathology for biobanking, biopharmaceutical studies, molecular assays, and the development of individualized medicine.<\/p>\n<p style=\"text-align: justify;\"><strong>Request Sample Pages:&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=844\" target=\"_blank\">https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=844<\/a><strong>&nbsp;<\/strong><a href=\"https:\/\/www.marketsandmarkets.com\/requestCustomizationNew.asp?id=844&amp;utm_source=prnewswire&amp;utm_medium=referral&amp;utm_campaign=paidpr\"  target=\"_blank\"><br \/><\/a><\/p>\n<p style=\"text-align: justify;\"><strong><span class=\"xn-location\">North America<\/span>&nbsp;dominates the digital pathology market during the forecast period.<\/strong><\/p>\n<p style=\"text-align: justify;\">In 2019,&nbsp;<span class=\"xn-location\">North America<\/span>&nbsp;accounted for the largest share of the market, followed by&nbsp;<span class=\"xn-location\">Europe<\/span>. Factors such as the high prevalence of cancer and increasing initiatives by industry players are driving the market in&nbsp;<span class=\"xn-location\">North America<\/span>. However, the&nbsp;<span class=\"xn-location\">Asia Pacific<\/span>&nbsp;region is expected to grow at the second-highest rate during the forecast period<\/p>\n<p style=\"text-align: justify;\">Leica Biosystems (US), Koninklijke Philips N.V. (<span class=\"xn-location\">Netherlands<\/span>), and Hamamatsu Photonics K.K. (<span class=\"xn-location\">Japan<\/span>) are the key players operating in the digital pathology market. Other prominent players in this market include Roche (<span class=\"xn-location\">Switzerland<\/span>), 3DHISTECH (<span class=\"xn-location\">Hungary<\/span>), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology (<span class=\"xn-location\">Canada<\/span>), Visiopharm A\/S (<span class=\"xn-location\">Denmark<\/span>), Corista (US),&nbsp;<span class=\"xn-person\">Indica Labs<\/span>&nbsp;(US), Objective Pathology Services (<span class=\"xn-location\">Canada<\/span>), Sectra AB (<span class=\"xn-location\">Sweden<\/span>), OptraSCAN (<span class=\"xn-location\">India<\/span>), Glencoe Software (US), KONFOONG BIOTECH INTERNATIONAL CO., LTD (<span class=\"xn-location\">China<\/span>), Inspirata Inc. (US), Mikroscan Technologies (US), Proscia Inc. (US), and Kanteron Systems (<span class=\"xn-location\">Spain<\/span>).<\/p>\n<p><span style='font-size:18px !important;'>Media Contact<\/span><br \/><strong>Company Name:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/companyname\/marketsandmarkets.com_17712.html\" rel=\"nofollow\">MarketsandMarkets<\/a><br \/><strong>Contact Person:<\/strong> Mr. Aashish Mehra<br \/><strong>Email:<\/strong> <a href=\"https:\/\/www.abnewswire.com\/email_contact_us.php?pr=digital-pathology-market-worth-1054-million-by-2025-key-players-are-leica-biosystems-us-koninklijke-philips-nv-netherlands\" rel=\"nofollow\">Send Email<\/a><br \/><strong>Phone:<\/strong> 18886006441<br \/><strong>Address:<\/strong>630 Dundee Road  Suite 430<br \/><strong>City:<\/strong> Northbrook<br \/><strong>State:<\/strong> IL 60062<br \/><strong>Country:<\/strong> United States<br \/><strong>Website:<\/strong> <a href=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/digital-pathology-market-844.html\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.marketsandmarkets.com\/Market-Reports\/digital-pathology-market-844.html<\/a><\/p>\n<p><object type=\"text\/html\" data=\"https:\/\/www.marketsandmarkets.com\/Market-Reports\/digital-pathology-market-844.html\" style=\"width:900px; height:400px;\"><\/object><img decoding=\"async\" src=\"https:\/\/www.abnewswire.com\/press_stat.php?pr=digital-pathology-market-worth-1054-million-by-2025-key-players-are-leica-biosystems-us-koninklijke-philips-nv-netherlands\" alt=\"\" width=\"1px\" height=\"1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The major players in the global digital pathology market are Leica Biosystems (US), Koninklijke Philips N.V. (Netherlands), Hamamatsu Photonics (Japan). Other prominent players in this market include Roche (Switzerland), 3DHISTECH (Hungary), Apollo Enterprise Imaging (US), XIFIN (US), Huron Digital Pathology &hellip; <a href=\"https:\/\/www.abnewswire.com\/pressreleases\/digital-pathology-market-worth-1054-million-by-2025-key-players-are-leica-biosystems-us-koninklijke-philips-nv-netherlands_559918.html\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,405,406,411,403],"tags":[],"class_list":["post-559918","post","type-post","status-publish","format-standard","hentry","category-Business","category-Health-Medicine","category-Pharmaceuticals-Biotech","category-Technology","category-UK"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559918","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=559918"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/559918\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=559918"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=559918"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=559918"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}